Feng Ye

4.0k total citations · 1 hit paper
57 papers, 1.1k citations indexed

About

Feng Ye is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Feng Ye has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in Feng Ye's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Colorectal and Anal Carcinomas (6 papers). Feng Ye is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Colorectal and Anal Carcinomas (6 papers). Feng Ye collaborates with scholars based in China, United States and United Kingdom. Feng Ye's co-authors include Xiaoming Xie, Hailin Tang, Yutian Zou, Xueqi Ou, Guanfeng Gao, Shaoquan Zheng, Lijuan Zhang, Han Ouyang, Peng Liu and Lu Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Feng Ye

49 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial

2024 45 citations Qiao Li, Qingyuan Zhang et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feng Ye China	18	475	431	333	223	131	57	1.1k
Xiaobin Gu China	21	343 0.7×	343 0.8×	749 2.2×	364 1.6×	140 1.1×	52	1.3k
Hans‐Christian Kolberg Germany	15	247 0.5×	356 0.8×	480 1.4×	205 0.9×	59 0.5×	84	966
Jennifer Ma United States	14	253 0.5×	185 0.4×	321 1.0×	169 0.8×	121 0.9×	54	817
Jacob R. Izbicki Germany	18	284 0.6×	257 0.6×	576 1.7×	357 1.6×	69 0.5×	47	1.3k
Xiao Shi China	15	278 0.6×	214 0.5×	196 0.6×	168 0.8×	118 0.9×	43	859
Yabing Cao China	15	191 0.4×	132 0.3×	350 1.1×	135 0.6×	189 1.4×	52	811
J.J. Lafitte France	13	296 0.6×	190 0.4×	504 1.5×	481 2.2×	126 1.0×	39	930
Roberta Cerutti Italy	18	234 0.5×	193 0.4×	343 1.0×	154 0.7×	283 2.2×	58	988
Vera Schellerer Germany	20	265 0.6×	160 0.4×	550 1.7×	270 1.2×	95 0.7×	60	1.1k
Xiaofan Lu China	17	391 0.8×	279 0.6×	245 0.7×	406 1.8×	67 0.5×	60	938

Countries citing papers authored by Feng Ye

Since Specialization

Citations

This map shows the geographic impact of Feng Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Ye more than expected).

Fields of papers citing papers by Feng Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Ye. The network helps show where Feng Ye may publish in the future.

Co-authorship network of co-authors of Feng Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Ye. A scholar is included among the top collaborators of Feng Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Ye. Feng Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Ying, Panpan Zhang, Ming Lu, et al.. (2025). Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial. Cancer Immunology Immunotherapy. 74(3). 83–83.

Chu, Tianqing, Xiaorong Dong, Huijuan Wang, et al.. (2024). Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors. European Journal of Cancer. 209. 114260–114260. 2 indexed citations

Ye, Feng, et al.. (2024). A Machine-Learning Model Based on Clinical Features for the Prediction of Severe Dysphagia After Ischemic Stroke. International Journal of General Medicine. Volume 17. 5623–5631. 2 indexed citations

Li, Qiao, Qingyuan Zhang, Quchang Ouyang, et al.. (2024). The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial. Nature Communications. 15(1). 1015–1015. 45 indexed citations breakdown →

Ye, Feng, Ting Xu, Ziyi Wu, et al.. (2023). Do all patients at the initial stage of nasopharyngeal carcinoma need bone metastasis screening? A retrospective study. Head & Neck. 45(6). 1476–1485. 1 indexed citations

You, A‐Bin, et al.. (2023). CMTR1 promotes colorectal cancer cell growth and immune evasion by transcriptionally regulating STAT3. Cell Death and Disease. 14(4). 245–245. 13 indexed citations

You, A‐Bin, et al.. (2023). A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer. Clinical Cancer Research. 29(11). 2095–2109. 32 indexed citations

Xu, Ying, Yi Yang, Lu Li, Feng Ye, & Xinming Zhao. (2022). The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy. Frontiers in Oncology. 12. 905260–905260. 2 indexed citations

Lei, Hui, Feng Ye, Xiaoqing Liu, et al.. (2020). SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients. Influenza and Other Respiratory Viruses. 14(6). 688–699. 60 indexed citations

10.

Ye, Feng, et al.. (2020). Intracranial primary Ewing's sarcoma/primitive neuroectodermal tumor with EWS-FLI1 fusion: one case report and literature review. Chinese Journal of Neuromedicine. 19(2). 191–193. 1 indexed citations

11.

Yang, Yi, Yi Chen, Feng Ye, et al.. (2020). Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival. European Radiology. 31(5). 3053–3064. 36 indexed citations

12.

Zheng, Jiani, Jingxun Wu, Chunyue Wang, et al.. (2020). Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis. PLoS ONE. 15(6). e0233571–e0233571. 18 indexed citations

13.

Wang, Xinle, Feng Ye, Mengqi Li, et al.. (2019). Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab. Medicine. 98(36). e16937–e16937. 5 indexed citations

14.

Li, Xiaozhi, Yumin Qiu, Feng Ye, et al.. (2018). A rare case of the dual origin of the right vertebral artery with an aortic arch origin of the left vertebral artery. European Journal of Anatomy. 22(5). 419–423.

15.

Zhou, Peizhi, Shizhen Zhang, Liang Lv, et al.. (2017). Clinical Features, Treatment, and Long-term Outcomes of Central Neurocytoma: A 20-Year Experience at a Single Center. World Neurosurgery. 109. e59–e66. 24 indexed citations

16.

Zhang, Hongmei, et al.. (2017). Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation. European Radiology. 27(9). 3845–3855. 35 indexed citations

17.

Hu, Xin, Yuan Fang, Feng Ye, et al.. (2014). Effects of plasma D-dimer levels on early mortality and long-term functional outcome after spontaneous intracerebral hemorrhage. Journal of Clinical Neuroscience. 21(8). 1364–1367. 32 indexed citations

18.

Liu, Peng, Hailin Tang, Bo Chen, et al.. (2014). miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer. Cancer Letters. 357(1). 384–392. 90 indexed citations

19.

Li, Hongtao, et al.. (2012). Safety of Telaprevir for Chronic Hepatitis C Virus Infection. Clinical Drug Investigation. 32(10). 665–672. 11 indexed citations

20.

Ye, Feng, Jiaxing Xie, Nuofu Zhang, et al.. (2011). Pulmonary alveolar microlithiasis: report of three cases and literature review. Chinese Journal of Asthma. 31(18). 1394–1398. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact